These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14102409)

  • 1. [CLINICAL EXPERIENCE WITH A NEW NEUROLEPTIC: R 1625 OR HALOPERIDOL].
    ACUSSERUIZ DG; MALUF L
    Prensa Med Argent; 1963 Aug; 50():2348-55. PubMed ID: 14102409
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE USE OF A BUTYROPHENONE NEUROLEPTIC (HALOPERIDOL) IN ACUTE AND CHRONIC PSYCHOSES].
    MADALENA JC; FERREIRA LR; BELLO H
    Rev Assoc Med Bras; 1963; 9():375-86. PubMed ID: 14163287
    [No Abstract]   [Full Text] [Related]  

  • 3. [EARLY CLINICAL EVALUATION OF THE NEUROLEPTIC PROPERTIES OF A NEW COMPOUND: DIBENZOTHIAZEPINE].
    DELAY J; DENIKER P; GINESTET D; P'ERON MAGNAN P
    Ann Med Psychol (Paris); 1964 Oct; 122():402-7. PubMed ID: 14205902
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL AND ELECTROMYOGRAPHIC ANALYSIS OF THE AKINETIC SYNDROME IN NEUROLEPTIC THERAPY].
    SUJECKA-SZYMKIEWICZ H; ZAKRZEWSKA F; GRABOWSKI K
    Neurol Neurochir Psychiatr Pol; 1965; 15():101-6. PubMed ID: 14348654
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON SOME ERRORS IN THE PRESCRIPTION OF PSYCHIATRIC DRUGS].
    DELAY J; DENIKER P
    Bull Mem Soc Med Hop Paris; 1965 Mar 5-12; 116():487-93. PubMed ID: 14346099
    [No Abstract]   [Full Text] [Related]  

  • 6. [COMPARATIVE STUDIES ON THE EFFECT OF ANTIDEPRESSIVE AND NEUROLEPTIC DRUGS ON THE POWER OF CONCENTRATION].
    HARTUNG ML; BENTE D; SCHNEEWIND KA
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:584-7. PubMed ID: 14253973
    [No Abstract]   [Full Text] [Related]  

  • 7. ELECTROENCEPHALOGRAPHIC EFFECTS OF LSD, AND SOME PSYCHIATRIC IMPLICATIONS.
    WERRE PF
    J Neuropsychiatr; 1964 Dec; 5():516-24. PubMed ID: 14246552
    [No Abstract]   [Full Text] [Related]  

  • 8. [PHARMACOLOGIC PRINCIPLES OF TREATMENT OF INTOXICATIONS WITH NEUROLEPTIC AND TRANQUILIZING AGENTS].
    TAESCHLER M; LOEW D
    Ther Umsch; 1965 Apr; 22():165-9. PubMed ID: 14297156
    [No Abstract]   [Full Text] [Related]  

  • 9. [RARE NEUROLOGICAL COMPLICATIONS IN NEUROLEPTIC THERAPY].
    WASIK A
    Neurol Neurochir Psychiatr Pol; 1964; 14():949-52. PubMed ID: 14293954
    [No Abstract]   [Full Text] [Related]  

  • 10. [ELECTROMYOGRAPHIC ANALYSIS OF THE EFFECT OF A SINGLE DOSE OF TRIHEXYPHENIDYL AND IMIPRAMINE ON EXTRAPYRAMIDAL DISORDERS DIAGNOSED IN NEUROLEPTIC THERAPY].
    ZAKRZEWSKA F; SZYMKIEWICZ H; GRABOWSKI K
    Neurol Neurochir Psychiatr Pol; 1963; 13():687-93. PubMed ID: 14091517
    [No Abstract]   [Full Text] [Related]  

  • 11. [UNIVERSAL FORREST'S TEST V IN CONTROLLING NEUROLEPTIC THERAPY IN SOME PATIENTS].
    BARTOSZEWSKI J; KLEINDIENST J; URBANSKI I
    Pol Tyg Lek; 1964 Nov; 19():1732-4. PubMed ID: 14321002
    [No Abstract]   [Full Text] [Related]  

  • 12. [First results of the treatment of 60 cases of mental disorders with a new neuroleptic agent, haloperidol (R 1625)].
    ALLEVA PM
    Riv Sper Freniatr Med Leg Alien Ment; 1960 Mar; 84():248-60. PubMed ID: 13792796
    [No Abstract]   [Full Text] [Related]  

  • 13. The critical role of clinical pharmacology in geriatric psychopharmacology.
    Pollock B; Forsyth C; Bies R
    Clin Pharmacol Ther; 2009 Jan; 85(1):89-93. PubMed ID: 19037202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with the neuroleptic haloperidol (R 1625)].
    OLES M
    Acta Neurol Psychiatr Belg; 1960 Jan; 60():100-7. PubMed ID: 14428635
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PROBLEM OF THE RELEVANCE OF THE CHARACTERISTIC ACTION OF NEUROLEPTIC SUBSTANCES TO CLINICAL RESULTS. PSYCHOMETRIC STUDIES WITH DIPIPERON].
    HEINRICH K; RUMPF K
    Arzneimittelforschung; 1964 Jun; 14():SUPPL:587-90. PubMed ID: 14253974
    [No Abstract]   [Full Text] [Related]  

  • 16. [NEUROLEPTIC ACTION OF A THIAZEPINE DERIVATIVE].
    BOISSIER JR; SIMON P; FICHELLE-PAGNY J
    C R Seances Soc Biol Fil; 1964; 158():1256-9. PubMed ID: 14210550
    [No Abstract]   [Full Text] [Related]  

  • 17. HUMAN PHARMACOLOGY AND PROGRESSIVE CLINICAL SCREENING OF A NEW PSYCHOACTIVE COMPOUND (CIBA 30,803 BA).
    STJEAN A; CSORBA T; NOE W; BAN TA
    Dis Nerv Syst; 1965 Jul; 26():430-4. PubMed ID: 14321268
    [No Abstract]   [Full Text] [Related]  

  • 18. [OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL].
    GALINDEZ L; SANTOS MR; BOREL RO
    Dia Med; 1963 Sep; 35():1435-6. PubMed ID: 14088362
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of a new neuroleptic of the butyrophenone group].
    VELLOSO FM; PAPROCKI J
    Hospital (Rio J); 1963 Jun; 63():1427-34. PubMed ID: 13996630
    [No Abstract]   [Full Text] [Related]  

  • 20. [R 1625, HALOPERIDOL. CHEMICOPHARMACOLOGICAL AND CLINICAL STUDY].
    ROSA JJ; SCHROEDER E; BARROSHURTADO A
    Rev Argent Neurol Psiquiatr; 1964; 1():262-7. PubMed ID: 14322256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.